Modern Methods of Herpes Treatment: from Traditional Antiviral Therapy through Vaccines, and Genetic Engineering (review)
- Authors: Murashkina S.1, Budanova E.V.2
-
Affiliations:
- First Medical State University
- I.M.Sechenov First Moscow state medical university
- Section: DERMATOLOGY
- Submitted: 06.03.2025
- Accepted: 22.04.2025
- Published: 27.07.2025
- URL: https://rjsvd.com/1560-9588/article/view/676901
- DOI: https://doi.org/10.17816/dv676901
- ID: 676901
Cite item
Full Text



Abstract
Herpesvirus infections caused by herpes simplex viruses (HSV-1 and HSV-2) constitute a global public health issue, affecting billions of people and entailing significant physical, emotional, and socioeconomic consequences. This review explores contemporary approaches to herpes treatment, ranging from traditional antiviral therapy (acyclovir, valacyclovir, famciclovir), which suppresses viral replication but does not eliminate latent viruses, to cutting-edge methods such as novel antiviral agents (pritelivir, amenamevir), vaccines (HSV529, RVx201, GEN-003), gene editing technologies (CRISPR-Cas9), and immunotherapy. Special emphasis is placed on HSV epidemiology, and its resistance to therapy, highlighting the urgent need for strategies eliminatinglatent viruses and alleviate the societal burden of the infection.
Full Text

About the authors
Sofya Murashkina
First Medical State University
Author for correspondence.
Email: Sofya_murashkina12@mail.ru
ORCID iD: 0009-0006-0624-960X
ResearcherId: MIK-9946-2025
Russian Federation
Elena Vyacheslavovna Budanova
I.M.Sechenov First Moscow state medical university
Email: e.v.budanova@mail.ru
ORCID iD: 0000-0003-1864-5635
MD, PhD, Sechenov University, Institute of Public Health, Department of microbiology , virology and immunology.
References
Supplementary files
